Lck-IN-1

Lck-IN-1 is a potent lymphocyte protein tyrosine kinase (Lck) inhibitor extracted from patent WO2007013673A1, example 48[1].

Product Specifications

CAS Number

923596-52-5

UNSPSC

12352005

Target

Src

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/lck-in-1.html

Purity

98.54

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CCCNC1=NN2C(C=C1)=NC=C2C3=CC=NC=C3

Molecular Formula

C14H15N5

Molecular Weight

253.30

References & Citations

[1]Kazuo Nakai, et al. Fused heterocycles as lck inhibitors. WO2007013673A1.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, protect from light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

RC214998A1V 250 µL

Human SLC13A2 (NM_003984) AAV Particle

View Details

NBP2-98647AF594 0.1 mL

Rabbit Polyclonal Nephronophthisis Antibody [Alexa Fluor 594]

View Details

T34592 25 mg

Sdz 215-811

View Details

ELI-41756h 96 Tests

Human Small VCP/p97-interacting protein,SVIP ELISA KIT

View Details

EF010977 96 Tests

Bovine HP ELISA Kit

View Details

orb2133191 100 µL

HOXB2 Rabbit Polyclonal Antibody (Biotin)

View Details